This is a contract award to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services, by the Food and Drug Administration (FDA). The contract, valued at $7,647,580.46, is a Blanket Purchase Agreement (BPA) call under a larger Regulatory Review Support Services BPA. The work to be performed includes AIRRS/CIRDS support, which likely refers to regulatory review and information systems support for the FDA. The contract is not set aside and has a period of...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) call contract to Booz Allen Hamilton Inc. for DRUG QUALITY AND SECURITY SERVICES - DQSA. The $10,600,837.15 contract, which has a completion date of July 15, 2020, was awarded on July 16, 2019 under the General Services Administration's (GSA) Professional Services Schedule (PSS). The contract is for labor hours services and does not have a set-aside designation. Booz...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a prominent management, technology, and engineering services firm. The contract, valued at $5,653,574.90, provides BSUFA program support services. The contract is not set aside for any specific business category and utilizes the Multiple Award Schedule (MAS) contract vehicle. Booz Allen Hamilton Inc. is the prime contractor, and the award was made on...
This federal contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Booz Allen Hamilton Inc., a leading management, technology, and engineering services firm. The contract, valued at $12,954,413.27, is a Blanket Purchase Agreement (BPA) call under the General Services Administration's (GSA) Information Technology (IT) Schedule 70 contract vehicle. The contract is for IT Lifecycle Development and Management Support services, with a period of performance through...
This is a $1,136,793.48 task order awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc. under the FDA Data Dashboards & Analytics Blanket Purchase Agreement (BPA). The task order is for the development and maintenance of an FDA data dashboard and import data services. This is an unrestricted, time-and-materials contract with a period of performance through September 2024. Booz Allen Hamilton has subcontracted a portion of the work to Office Remedies, Inc., a...
The Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) call valued at $1,859,817.04 to Booz Allen Hamilton Inc. to provide services related to the implementation of the FDA's Opioid System Model and policy analysis. This contract is not set aside and is part of the Multiple Award Schedule (MAS) contract vehicle. Booz Allen Hamilton Inc. is a leading management, technology, and engineering services provider with a strong track record of supporting federal agencies,...
This contract award is a Blanket Purchase Agreement (BPA) call issued by the Food and Drug Administration (FDA) for data dashboards and analytics services. The $435,570.21 ceiling value contract was awarded to the prime contractor, Booz Allen Hamilton Inc., on February 28, 2024, with a period of performance through April 16, 2025. The contract is not designated as a set-aside. Booz Allen Hamilton Inc. is a prominent management, technology, and engineering services firm that provides a wide range...
Booz Allen Hamilton Inc. was awarded a $33.4 million firm-fixed-price blanket purchase agreement call contract by the Department of Health and Human Services' Food and Drug Administration to provide services supporting existing systems. Under the terms of the multiple award schedule contract, Booz Allen will implement new features and products for the FDA in accordance with the statement of work. Performance will take place in McLean, Virginia over a three-year period through October 2024....
The Department of Health and Human Services Food and Drug Administration awarded a delivery order contract to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services to the U.S. government. The $484,929.80 Firm Fixed Price contract is for the evaluation of the implementation of a Benefit-Risk Framework, which falls under the CDER (Center for Drug Evaluation and Research) Priority Analysis major program. The contract has a completion date of September 3,...
This is a delivery order awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a leading management, technology, and engineering services firm. The $527,543.27 firm fixed-price contract is for a SCIENTIFIC STUDY under the CDER Priority Analysis IDIQ (Indefinite Delivery/Indefinite Quantity) contract. The award has no set-aside designation and the ultimate completion date is May 26, 2017. Booz Allen Hamilton Inc. is a federal prime contractor that also holds other...